Potassium Citrate IP is a pharmaceutical-grade compound that serves as a vital source of potassium and citrate ions. It is commonly used in medicinal formulations due to its alkalizing properties, which help regulate the body's acid-base balance. As a highly soluble and bioavailable form of potassium, it plays an essential role in electrolyte balance, supporting various physiological functions such as nerve signaling, muscle contractions, and heart health. Its buffering capacity makes it a preferred ingredient in formulations requiring pH regulation.

One of the primary medical applications of Potassium Citrate IP is in the prevention and treatment of kidney stones, particularly those caused by high levels of calcium or uric acid. By increasing urinary pH and citrate levels, it reduces the crystallization of stone-forming minerals, thereby decreasing the risk of stone formation. It is often prescribed for individuals prone to recurrent kidney stones or conditions like renal tubular acidosis. Additionally, it is used as a urinary alkalizer to manage conditions such as metabolic acidosis and certain urinary tract disorders.

Beyond its role in kidney health, Potassium Citrate IP is also utilized as a potassium supplement in cases of hypokalemia (low potassium levels). Maintaining adequate potassium levels is crucial for proper muscle function, nerve transmission, and cardiovascular stability. It is commonly included in oral solutions and effervescent tablets to provide controlled potassium supplementation. Due to its safety and effectiveness, Potassium Citrate IP remains a widely used pharmaceutical ingredient for various therapeutic and nutritional applications.